Legal Representation
Attorney
Marie A. Lavalleye, Esq.
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 17, 2012 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 16, 2012 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 14, 2011 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 19, 2011 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 19, 2011 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 10, 2011 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 7, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 2, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Dec 2, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of diabetes and cardiovascular diseases including hyperlipidemia, atherosclerosis, myocardial infarction, angina pectoris and stroke
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005